Pharmacokinetics and pharmacogenomics study how genetic variations influence an individual's response to drugs. While pharmacokinetics focuses on single-gene effects, pharmacogenomics considers the impact of the entire genome. These fields enable personalized therapy by predicting drug efficacy, optimal dosing, and risk of adverse reactions. Advances in genetic testing and bioinformatics are making personalized medicine more accessible. Research applications range from oncology to psychiatry, where genetic profiles guide treatment selection. Ethical, regulatory, and cost considerations remain important as these approaches integrate into routine clinical practice.
sub tracks:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
